Larotrectinib, a TRK inhibitor, in children and adults patients with NTRK fusion cancer
Larotrectinib is being investigated to potentially treat adult and pediatric patients with locally advanced or metastatic solid tumors with a neurotrophic tyrosine receptor kinase ( NTRK ) gene fusion ...
read article